A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Jazz Pharmaceuticals
Jazz Pharmaceuticals
AstraZeneca
Baylor College of Medicine
University of Nebraska
VM Oncology, LLC
Cancer Research UK
LigaChem Biosciences, Inc.
University of Colorado, Denver
Jonsson Comprehensive Cancer Center